Literature DB >> 7496309

Decision analysis and screening for Down's syndrome. Costs were overestimated.

T M Reynolds.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7496309      PMCID： PMC2551271          DOI： 10.1136/bmj.311.7016.1372

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Using decision analysis to compare policies for antenatal screening for Down's syndrome.

Authors:  J Fletcher; N R Hicks; J D Kay; P A Boyd
Journal:  BMJ       Date:  1995-08-05

2.  Utility of unconjugated estriol in screening for Down syndrome is not proven.

Authors:  T Reynolds; R John; K Spencer
Journal:  Clin Chem       Date:  1993-09       Impact factor: 8.327

3.  Serum screening for Down's syndrome.

Authors:  A J Dawson; G Jones; M S Matharu; T M Reynolds; M D Penney; R John; M Creasy; P Gregory
Journal:  Br J Obstet Gynaecol       Date:  1993-09

4.  Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.

Authors:  K Spencer; E J Coombes; A S Mallard; A M Ward
Journal:  Ann Clin Biochem       Date:  1992-09       Impact factor: 2.057

5.  Age-specific detection and false-positive rates: an aid to counseling in Down syndrome risk screening.

Authors:  T M Reynolds; A B Nix; F D Dunstan; A J Dawson
Journal:  Obstet Gynecol       Date:  1993-03       Impact factor: 7.661
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.